Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

icad inc. - Common Stock (NQ:ICAD)

3.720 +0.010 (+0.27%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about icad inc. - Common Stock

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash. 
Via Benzinga
icad: Q2 Earnings Insights
  icad (NASDAQ:ICAD) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For May 11, 2022
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter. 
Via Benzinga
Recap: icad Q4 Earnings
icad (NASDAQ:ICAD) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings icad missed... 
Via Benzinga
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (... 
Via Benzinga
7 Super Speculative Stocks That Could Make You Very Rich
With the "big money" buying growth stocks, retail investors can look for good, speculative stocks to buy at this point. 
Via InvestorPlace
3 AI Stocks to Buy for the Future of Automation
Increased appreciation for AI and the Street's reduced hostility to growth stocks make this a good time to find AI stocks to buy. 
Via InvestorPlace
7 Drug Stocks That Will Soar in 2023
These drug stocks to buy look poised to generate huge profits for investors in 2023 and in subsequent years. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Elbit Systems Shares Are Trading Lower By Over 10%; Here Are 24 Stocks Moving Premarket
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares rose 26.3% to $0.7994 in pre-market trading after the company received FDA 510K premarket clearance for PainShield Plus, its dual-actuator ultrasound... 
Via Benzinga
iCAD Stock Swings Higher On Google Health Agreement: What's Going On?
Icad Inc (NASDAQ: ICAD) shares are trading higher Monday after the company announced a strategic development and commercialization agreement with Alphabet Inc's (NASDAQ: GOOG)  
Via Benzinga
7 Little-Known Stocks With Millionaire-Maker Potential
The unprecedented number of tech revolutions has made it easier than ever to identify many potential millionaire-maker stocks to buy. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 44 companies hit new 52-week lows. 
Via Benzinga
Earnings Outlook For icad
  icad (NASDAQ:ICAD) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement. Analysts estimate that icad will report an... 
Via Benzinga
5 Growth Stocks to Buy Now
EPS estimates are generally a strong indication of future growth. That's just one part of finding reliable growth stocks. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers 
Via Benzinga
icad: Q1 Earnings Insights
icad (NASDAQ:ICAD) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings icad missed estimated earnings by 16.67%,... 
Via Benzinga
A Preview Of icad's Earnings
icad (NASDAQ:ICAD) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that icad will report an... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two... 
Via Benzinga
icad Earnings Preview
icad (NASDAQ:ICAD) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
7 of the Best Cheap Stocks Under $10 for 2022 to Buy Now
These cheap stocks under $10 are poised to rally in the new, more friendly macro environment that's in place as 2022 unfolds. 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 236 companies hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
Upgrades Canaccord Genuity upgraded the previous rating for Fortuna Silver Mines Inc (NYSE: 
Via Benzinga
45 Biggest Movers From Yesterday
Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced... 
Via Benzinga
Mid-Afternoon Market Update: Dow Jumps 250 Points; Avrobio Shares Slide
Toward the end of trading Tuesday, the Dow traded up 0.70% to 36,839.62 while the NASDAQ fell 1.57% to 15,583.77. The S&P also fell, dropping 0.03% to 4,794.93. The U.S. has... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Hoth Therapeutics (NASDAQ: 
Via Benzinga
Mid-Day Market Update: Nasdaq Dips 250 Points; TherapeuticsMD Shares Surge
Midway through trading Tuesday, the Dow traded up 0.66% to 36,827.65 while the NASDAQ fell 1.63% to 15,574.50. The S&P also fell, dropping 0.08% to 4,792.93. The U.S. has the... 
Via Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.